Cargando…

Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus

Oncolytic viruses (OVs) represent promising therapeutic agents for cancer therapy by selective oncolysis and induction of anti-tumor immunity. OVs can be engineered to express tumor-associated antigens and immune-modulating agents to provoke stronger antitumor immunity. Here, we engineered vaccinia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Jing, Jin, Chuan, Čančer, Matko, Wang, Hai, Ramachandran, Mohanraj, Yu, Di
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182386/ https://www.ncbi.nlm.nih.gov/pubmed/34141872 http://dx.doi.org/10.1016/j.omto.2021.04.016

Ejemplares similares

IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
por: Martikainen, Miika, et al.
Publicado: (2021)

Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity
por: Sarén, Tina, et al.
Publicado: (2017)

Reconstitution of Semliki forest virus membrane
Publicado: (1977)

Cholesterol is required for infection by Semliki Forest virus
Publicado: (1991)

Membrane fusion mutants of Semliki Forest virus
Publicado: (1984)

Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
por: Liu, Liqiong, et al.
Publicado: (2022)

Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity
por: Hirvinen, Mari, et al.
Publicado: (2016)

Cholesterol is required in the exit pathway of Semliki Forest virus
Publicado: (1993)

On the entry of semliki forest virus into BHK-21 cells
por: Helenius, Ari, et al.
Publicado: (1980)

Theranostic Potential of Oncolytic Vaccinia Virus
por: Rojas, Juan J, et al.
Publicado: (2012)

Immunotherapeutic Potential of Oncolytic Vaccinia Virus
por: Thorne, Steve H.
Publicado: (2014)

The oligomerization reaction of the Semliki Forest virus membrane protein subunits
Publicado: (1995)

Mechanisms of mutations inhibiting fusion and infection by Semliki Forest virus
Publicado: (1996)

Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses
Publicado: (1981)

Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice
por: Chen, Nanhai G, et al.
Publicado: (2011)

Enhancement of Antitumor Immunity Using a DNA-Based Replicon Vaccine Derived from Semliki Forest Virus
por: Zhang, Liang, et al.
Publicado: (2014)

Semliki Forest virus strongly reduces mosquito host defence signaling
por: Fragkoudis, R, et al.
Publicado: (2008)

Structural Plasticity of the Semliki Forest Virus Glycome upon Interspecies Transmission
por: Crispin, Max, et al.
Publicado: (2014)

Differential effects of lipid biosynthesis inhibitors on Zika and Semliki Forest viruses
por: Royle, Jamie, et al.
Publicado: (2017)

Semliki Forest virus-induced polykaryocyte formation is an ATP-dependent event
por: Kempf, C., et al.
Publicado: (1987)

Semliki Forest Virus: A Probe for Membrane Traffic in the Animal Cell
por: Simons, Kai, et al.
Publicado: (1984)

Oncolytic Vaccinia Virus in Lung Cancer Vaccines
por: Truong, Cao-Sang, et al.
Publicado: (2022)

Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety
por: Ge, Yan, et al.
Publicado: (2020)

Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma
por: Herrador-Cañete, Guillermo, et al.
Publicado: (2022)

Luteolin enhances the antitumor efficacy of oncolytic vaccinia virus that harbors IL‐24 gene in liver cancer cells
por: Wang, Chunming, et al.
Publicado: (2020)

Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia
por: Wang, Weiyi, et al.
Publicado: (2021)

Properties of non-structural protein 1 of Semliki Forest virus and its interference with virus replication
por: Kiiver, Kaja, et al.
Publicado: (2008)

Expression and Immunogenicity of Recombinant African Swine Fever Virus Proteins Using the Semliki Forest Virus
por: Fang, Niran, et al.
Publicado: (2022)

pH-induced alterations in the fusogenic spike protein of Semliki Forest virus
Publicado: (1985)

Interactions of Semliki Forest virus spike glycoprotein rosettes and vesicles with cultured cells
Publicado: (1983)

Properties and use of novel replication-competent vectors based on Semliki Forest virus
por: Rausalu, Kai, et al.
Publicado: (2009)

Polyprotein Processing as a Determinant for In Vitro Activity of Semliki Forest Virus Replicase
por: Pietilä, Maija K., et al.
Publicado: (2017)

Demyelination in mice resulting from infection with a mutant of Semliki Forest virus
por: Sheahan, B. J., et al.
Publicado: (1981)

Differences in antigenicity of E2 in Semliki Forest virus particles and in infected cells
por: Repges-Illguth, S., et al.
Publicado: (1994)

Structure and interaction with lipid membrane models of Semliki Forest virus fusion peptide
por: Agopian, A., et al.
Publicado: (2016)

Targeting hematologic malignancies with oncolytic vaccinia virus constructs
por: Chen, Nanhai, et al.
Publicado: (2013)

HP-NAP of Helicobacter pylori: The Power of the Immunomodulation
por: Codolo, Gaia, et al.
Publicado: (2022)

Fusion of Semliki forest virus with the plasma membrane can be induced by low pH
Publicado: (1980)

Oligodendrocyte infection and demyelination produced in mice by the M9 mutant of Semliki Forest virus
por: Sheahan, B. J., et al.
Publicado: (1983)

(UV inactivation of Semliki Forest virus and)(E. coli)(bacteria by alternative light sources)
por: Skudra, Atis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ge0h113aiaocavvd9ke1ifcam